Plus Therapeutics, Inc. · NASDAQ:PSTV

Hawkins Richard J exercised options for 922 Plus Therapeutics, Inc. shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 1, 2026

On Jul 1, 2026, Hawkins Richard J (Director) exercised options for 922 Plus Therapeutics, Inc. shares, leaving 1,529 shares. Filed Jul 1, 2026 (Form 4).

Options exercised
922 shares
Holding after
1,529 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Common StockOption exercise9221,529Direct

Source

View original at SEC

Related